Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,201

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,201 results for “oncology”

Learn how ShareScore rates datasets ↗
geo20/100

Children's Oncology Group Study 9906 for High-Risk Pediatric ALL

GEO Series GSE11877. Homo sapiens. 207 samples. Type: Expression profiling by array.

openGEO-OpenJun 2009View details →
geo20/100

Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: an NRG Oncology / Gynecologic Oncology Group Study

GEO Series GSE120490. Homo sapiens. 145 samples. Type: Expression profiling by array.

openGEO-OpenDec 2022View details →
geo20/100

SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3-BASED GLIOMA PATIENT STRATIFICATION AND APPLICATION IN PRECISION ONCOLOGY

GEO Series GSE117905. Homo sapiens. 16 samples. Type: Expression profiling by array.

openGEO-OpenJun 2019View details →
geo20/100

The OncoLoop Network-based Precision Oncology Framework

GEO Series GSE186566. Mus musculus. 112 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenOct 2022View details →
geo20/100

Expression data from ALL samples for patients included in the Dutch Childhood Oncology Group

GEO Series GSE13351. Homo sapiens. 107 samples. Type: Expression profiling by array.

openGEO-OpenJan 2009View details →
geo20/100

Early Response and Outcome in High-Risk Childhood Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study

GEO Series GSE7440. Homo sapiens. 99 samples. Type: Expression profiling by array.

openGEO-OpenFeb 2008View details →
geo20/100

Genomic validation of the revised Bethesda criteria in terms of pathogenesis and oncologic significance

GEO Series GSE132024. Homo sapiens. 98 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenNov 2020View details →
geo20/100

Gene expression profiling of pediatric adrenocortical tumors of patients treated on the Children's Oncology Group XXX protocol.

GEO Series GSE76019. Homo sapiens. 34 samples. Type: Expression profiling by array.

openGEO-OpenDec 2016View details →
geo20/100

Histological Pattern of Tumor Inflammation and Stromal Density Correlate with Patient’s Demographics and Immuno-Oncologic Transcriptional Profile in Oral Squamous Cell Carcinoma

GEO Series GSE220863. Homo sapiens. 8 samples. Type: Expression profiling by array.

openGEO-OpenMay 2024View details →
geo20/100

Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group

GEO Series GSE63157. Homo sapiens. 85 samples. Type: Expression profiling by array.

openGEO-OpenNov 2014View details →
geo20/100

caArray_EXP-520: Gene Expression Profiles Predictive of Outcome and Age in Infant Acute Lymphoblastic Leukemia: a Children's Oncology Group Study

GEO Series GSE68720. Homo sapiens. 97 samples. Type: Expression profiling by array.

openGEO-OpenMay 2015View details →
NCCR Data Platform20/100

Children's Oncology Group (COG)

Data for patients enrolled in Children's Oncology Group studies, including clinical trials and registry protocols.

controlledView details →
NCCR Data Platform20/100

Radiation Oncology

Radiation-treatment data from NCI-supported Cancer Centers and the Pediatric Proton/Photon Consortium Registry.

controlledView details →
zenodo20/100

Dataset related to article "The Complementary Role of PSMA Expression and [18F]FDG PET/CT in Predicting Thyroid Cancer Outcome - from Black and White to Shades of Gray, in the Era of Precision Oncology"

<p>This record contains data related to article &quot;<strong>The Complementary Role of PSMA Expression and [<sup>18</sup>F]FDG PET/CT in Predicting Thyroid Cancer Outcome&nbsp;- from Black and White to Shades of Gray, in the Era of Precision Oncology</strong>&quot;</p> <p>Abstract<br> Background The value of Prostate Specific Membrane Antigen (PSMA) in thyroid carcinoma (TC) is still unknown. We<br> aimed to test the potential complementary role of PSMA expression and 2-[18F]fluoro-2-deoxy-D-glucose ([<br> 18F]FDG)<br> uptake on PET/CT as biomarkers for TC outcome prediction.<br> Materials and methods From a retrospective cohort of TC patients we selected those fulfilling the following inclusion/<br> exclusion criteria: thyroidectomy in our Institution, available primary tumor tissue PSMA immunostaining, [<br> 18F]<br> FDG PET/CT and follow-up data. PSMA staining was visually assessed. PET/CT was considered positive in case of [<br> 18F]<br> FDG uptake higher than the background at the site of TC confirmed by cyto-/histology, and/or follow-up. Disease<br> recurrence, radioiodine refractoriness (RAI-R) and status at last follow-up (LFU) were used as outcome endpoints.<br> Results We included 23 subjects. Disease recurrence occurred in 18 patients (median time 11 months, range 1&ndash;40);<br> among these 12/18 developed RAI-R (median time 28 months, range 2&ndash;221), and 13/18 had evidence of disease at<br> LFU. PSMA expression was negative in 6/23 cases. PET/CT was negative in 11/23 patients (7/11 experienced recurrence).<br> PET/CT was positive in 9/12 patients showing RAI-R and 10/13 cases with evidence of disease at LFU. All<br> patients with positive PET/CT had a positive PSMA immunostaining. Six out of 11 patients with negative PET/CT were<br> positive at immunostaining, showing lower PSMA expression (median score of 30%, range 0&ndash;80%) than patients with<br> positive PET/CT. The TC samples without PSMA expression belonged to patients who resulted negative also at PET/CT<br> (3 experienced recurrence, 2 were RAI-R, and 1 had disease at LFU). Four out of 11 patients who resulted negative at<br> PET/CT exhibited very high PSMA expression (&ge; 70%) and although 3 of them experienced recurrence, none resulted<br> RAI-R, and only 1 had persistent disease at LFU.<br> Conclusions Primary tumor PSMA expression and [<br> 18F]FDG uptake seem to play a complementary prognostic role in<br> TC. The majority of patients who expressed PSMA recurred. In the intermediate ATA risk class, patients with negative<br> PSMA immunostaining recurred less than patients expressing PSMA. Additionally, although patients with a negative</p>

restrictedApr 2023View details →
ClinicalTrials.gov20/100

Support of the Sexual Health in Oncology

ClinicalTrials.gov study NCT03166774. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)

ClinicalTrials.gov study NCT01402830. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

The Efficacy of Implementing Nurse-performed Ultrasound-guided Peripheral Intravenous Access in Oncology Patients

ClinicalTrials.gov study NCT06578494. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Digital Application Usage for Adherence of Patients Undergoing Robotic Assisted Radical Prostatectomy Following Oncological and Postoperative Functional Outcomes

ClinicalTrials.gov study NCT02809495. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC

ClinicalTrials.gov study NCT06396754. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

A Randomized, Controlled, Multicenter, Noninferiority Clinical Study of Perioperative and Oncological Safety in Patients With Rectal Cancer

ClinicalTrials.gov study NCT05503381. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record